Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study TW Laetsch, SG DuBois, L Mascarenhas, B Turpin, N Federman, ... The Lancet Oncology 19 (5), 705-714, 2018 | 555 | 2018 |
Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors ER Rudzinski, CM Lockwood, BA Stohr, SO Vargas, R Sheridan, JO Black, ... The American journal of surgical pathology 42 (7), 927-935, 2018 | 204 | 2018 |
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas SG DuBois, TW Laetsch, N Federman, BK Turpin, CM Albert, ... Cancer 124 (21), 4241-4247, 2018 | 142 | 2018 |
Expanding the spectrum of pediatric NTRK-rearranged mesenchymal tumors JL Davis, CM Lockwood, B Stohr, C Boecking, A Al-Ibraheemi, SG DuBois, ... The American journal of surgical pathology 43 (4), 435-445, 2019 | 126 | 2019 |
Infantile NTRK-associated Mesenchymal Tumors JL Davis, CM Lockwood, CM Albert, K Tsuchiya, DS Hawkins, ... Pediatric and Developmental Pathology 21 (1), 68-78, 2018 | 118 | 2018 |
TRK fusion cancers in children: a clinical review and recommendations for screening CM Albert, JL Davis, N Federman, M Casanova, TW Laetsch Journal of Clinical Oncology 37 (6), 513-524, 2019 | 111 | 2019 |
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without … AR Weiss, YL Chen, TJ Scharschmidt, YY Chi, J Tian, JO Black, JL Davis, ... The lancet oncology 21 (8), 1110-1122, 2020 | 98 | 2020 |
NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including … JT Rabban, WP Devine, AR Sangoi, L Poder, E Alvarez, JL Davis, ... Histopathology 77 (1), 100-111, 2020 | 80 | 2020 |
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their … MA Atiq, JL Davis, JL Hornick, BC Dickson, CDM Fletcher, JA Fletcher, ... Modern Pathology 34 (1), 95-103, 2021 | 73 | 2021 |
EWSR1-NFATC2 translocation-associated sarcoma clinicopathologic findings in a rare aggressive primary bone or soft tissue tumor GY Wang, DG Thomas, JL Davis, T Ng, RM Patel, PW Harms, BL Betz, ... The American Journal of Surgical Pathology 43 (8), 1112-1122, 2019 | 73 | 2019 |
Special AT‐rich sequence‐binding protein 2 (SATB 2) expression is sensitive but may not be specific for osteosarcoma as compared with other high‐grade primary bone sarcomas JL Davis, AE Horvai Histopathology 69 (1), 84-90, 2016 | 59 | 2016 |
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma AJ Penning, A Al-Ibraheemi, M Michal, BT Larsen, SJ Cho, CM Lockwood, ... Modern Pathology 34 (8), 1530-1540, 2021 | 51 | 2021 |
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms JL Davis, SO Vargas, ER Rudzinski, JM López Marti, K Janeway, ... Histopathology 76 (7), 1032-1041, 2020 | 51 | 2020 |
Mesenchymal neoplasms with NTRK and other kinase gene alterations JL Davis, A Al‐Ibraheemi, ER Rudzinski, LF Surrey Histopathology 80 (1), 4-18, 2022 | 42 | 2022 |
EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural … M Michal, BP Rubin, A Agaimy, K Kosemehmetoglu, ER Rudzinski, ... Modern Pathology 34 (4), 770-785, 2021 | 42 | 2021 |
EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature JN Cohen, AJ Sabnis, G Krings, SJ Cho, AE Horvai, JL Davis Human pathology 81, 281-290, 2018 | 41 | 2018 |
Syndrome‐associated soft tissue tumours CM Coffin, JL Davis, SC Borinstein Histopathology 64 (1), 68-87, 2014 | 40 | 2014 |
PAX2 expression in Wilms tumors and other childhood neoplasms JL Davis, L Matsumura, DA Weeks, ML Troxell The American journal of surgical pathology 35 (8), 1186-1194, 2011 | 30 | 2011 |
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma S Banerjee, CL Corless, MM Miettinen, S Noh, R Ustoy, JL Davis, ... Journal of translational medicine 17, 1-8, 2019 | 27 | 2019 |
Management of central nervous system teratoma CC Zygourakis, JL Davis, G Kaur, CP Ames, N Gupta, KI Auguste, ... Journal of Clinical Neuroscience 22 (1), 98-104, 2015 | 24 | 2015 |